Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study.

Jerome SarrisGerard J ByrneChad A BousmanLachlan CribbKaren M SavageOliver HolmesJenifer MurphyPatricia MacdonaldAnika ShortSonia NazarethEmma JenningsStuart R ThomasEdward OgdenSuneel ChamoliAndrew ScholeyCon Stough

Published in: The Australian and New Zealand journal of psychiatry (2019)

While research has generally supported Kava in non-clinical populations (potentially for more 'situational' anxiety as a short-term anxiolytic), this particular extract was not effective for diagnosed generalised anxiety disorder.

Keyphrases

double blind
placebo controlled
clinical trial
phase ii
phase iii
study protocol
oxidative stress
open label
sleep quality
randomized controlled trial
physical activity